Cleared Traditional

K924710 - TRIGLYCERIDES

K924710 is the FDA 510(k) clearance for TRIGLYCERIDES by Em Diagnostic Systems, Inc.. It is a Class 1 Chemistry device (product code CDT) cleared through the Traditional 510(k) pathway after a 130-day FDA review.

K924710 · Em Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1993
Decision
130d
Days
Class 1
Risk

K924710 is an FDA 510(k) clearance for the TRIGLYCERIDES. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Em Diagnostic Systems, Inc. (Gibbstown, US). The FDA issued a Cleared decision on January 26, 1993 after a review of 130 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Em Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K924710 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 18, 1992
Decision Date January 26, 1993
Days to Decision 130 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 88d · This submission: 130d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 112
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K924710.
TRIGLYCERIDES (GLYCEROL BLANKING) REAGENT SYSTEM
K952741 · Medical Diagnostic Technologies, Inc. · Aug 1995
TRIGLYCERIDES
K931891 · Em Diagnostic Systems, Inc. · Aug 1993
TRIGLYCERIDES GPO-PAP
K923508 · Randox Laboratories, Ltd. · Jul 1993
SYSTEMATE PLUS TRIGLYCERIDE-GLYCEROL BLANKED TEST
K924573 · Em Diagnostic Systems, Inc. · Nov 1992
LIPASE HYDROLYSIS/GLYCEROT KINASE ENZYME, TRIGLYC
K924694 · Olympus Corp. · Oct 1992
KING DIAGNOSTIC TRIGLYCERIDES REAGENT
K922964 · King Diagnostics, Inc. · Aug 1992